每日自适应放疗可能对头颈鳞癌危及器官剂量产生负面影响
本研究制定了一套定义靶区与危及器官剂量标准的方案,并在80例(2170分次)头颈鳞癌患者的回顾性队列中比较每日自适应放疗与非自适应放疗的计划符合性。结果显示,2 mm 外扩时每日自适应放疗显著减少方案违反(7% 对 20.3%,p < 0.001),而5 mm 外扩时无显著差异(15.1% 对 17.3%,p > 0.8);较大外扩因强制完整 PTV 覆盖而增加 OAR 剂量。将自适应限制在初始存在违反的分次可减少新发违反。
要点
- 2 mm 外扩时每日自适应放疗显著减少方案违反(7% 对 20.3%)。
- 5 mm 外扩时每日自适应放疗未显著减少方案违反。
- 较大外扩因强制完整 PTV 覆盖而增加 OAR 剂量。
核心结论
- 每日自适应放疗联合2 mm 外扩可改善靶区覆盖并减少方案违反,但较大外扩会增加危及器官剂量。
研究设计与样本
- 回顾性队列研究,纳入80例接受60.0-68.0 Gy(2 Gy/分次)放疗的头颈鳞癌患者,共2170分次。
- 制定定义靶区和危及器官剂量标准的方案,并用于评估每日自适应放疗与非自适应放疗计划。
- 从每日kVCT生成合成CT,并通过可变形图像配准传播轮廓。
主要发现
- 2 mm 外扩时,每日自适应放疗方案违反率为7%,非自适应放疗为20.3%(p < 0.001)。
- 5 mm 外扩时,每日自适应放疗方案违反率为15.1%,非自适应放疗为17.3%(p > 0.8)。
- 2 mm 外扩时,每日自适应放疗解决了610项违反但新引入152项违反。
- 5 mm 外扩时,每日自适应放疗解决了391项违反但新引入472项违反。
- 将自适应限制于初始存在违反的分次时,新引入违反减少(2 mm:60;5 mm:49)。
关键数值与推荐
- 方案定义了靶区和危及器官的剂量评估标准,用于判断是否需要自适应放疗。
临床怎么用
- 每日自适应放疗采用2 mm PTV 外扩可减少方案违反并改善靶区覆盖。
- 较大PTV 外扩可能因强制完整覆盖而增加危及器官剂量,需权衡。
- 将每日自适应放疗限制在初始存在方案违反的分次可减少新发违反。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Adaptive radiotherapy (ART) accounts for anatomical changes during treatment and may improve target coverage and spare organs-at-risk (OARs) in head and neck squamous cell carcinoma (HNSCC). This study aimed to develop a protocol defining dose evaluation criteria for target volumes and OARs to assess the need for ART. The protocol was applied to compare compliance between daily-ART and non-ART plans with varying CTV-PTV-margins. MATERIALS AND METHODS: A protocol defining dose criteria for target and OAR volumes was developed and used to evaluate ART in a retrospective cohort of 80 patients (2,170 fractions) treated with radiotherapy to 60.0-68.0 Gy (2 Gy/fraction). Synthetic CTs were generated from daily kVCTs and contours propagated using deformable image registration. Delivered doses (no-ART) and daily-ART treatments using 5 mm and 2 mm PTV plans were simulated. All daily distributions were evaluated using the protocol. RESULTS: With 2 mm margins, daily-ART significantly reduced protocol violations compared to no-ART(7% vs 20.3%, p < 0.001), while no significant difference was observed with 5 mm margins(15.1% vs 17.3%, p > 0.8). For 2 mm margins, daily-ART resolved 610 violations but introduced 152 new violations. With 5 mm margins, 391 violations were resolved, while 472 violations were introduced. When adaptation was limited to fractions that initially presented violations, fewer new violations were introduced (2 mm: 60; 5 mm: 49). CONCLUSION: Daily-ART with 2 mm margins improved target coverage and reduced protocol violations, while larger margins increased OAR doses by enforcing full PTV coverage. Restricting daily ART to fractions with identified violations minimized the occurrence of newly introduced violations.
引用
- Enocson H, Haraldsson A, Engström P, et al. Daily adaptive radiotherapy in head and neck squamous cell carcinoma can negatively impact organ at risk dosimetry. Clin Transl Radiat Oncol. 2026. PMID: 42281957. doi:10.1016/j.ctro.2026.101205
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。